Highlights - EMA - European Alliance of Associations for Rheumatology (EULAR) bilateral meeting - March 2026
Electronic application form (eAF) Q&A clinic, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 March 2026, 11:00 (CET) to 9 March 2026, 12:00 (CET)
Notices and alerts per role - CTIS Training Programme - Module 07
Avtozma
New product information wording - Extracts from PRAC recommendations on signals adopted at the 9-12 March 2026 PRAC
PRAC recommendations on signals adopted at the 9-12 March 2026 PRAC meeting
List of signals discussed at PRAC since September 2012
Human medicines European public assessment report (EPAR): Keppra, levetiracetam, Date of authorisation: 29/09/2000, Revision: 58, Status: Authorised
Human medicines European public assessment report (EPAR): Ilumira, lutetium (177Lu) chloride, Date of authorisation: 26/03/2026, Status: Authorised
Minutes of the COMP meeting 17-19 February 2026